Myriad Genetics alternatives and competitors
The closest alternatives to Myriad Genetics are Invitae, Ambry Genetics, Helix and Allelica.
Myriad Genetics is a genetic testing company in Salt Lake City, Utah, listed on NASDAQ as MYGN, that runs its tests in its own accredited laboratories.
10 alternatives to Myriad Genetics
What each product does, with its price as the vendor publishes it.
-
I
Invitae is a genetic testing brand owned by Labcorp, which acquired the business in 2024 after Invitae's bankruptcy. It keeps its own site and test menu and now presents itself as Invitae and Labcorp together, with some billing handled by Labcorp Genetics.
Price: No published price
-
A
Ambry Genetics is a genetic testing laboratory in Aliso Viejo, California, founded in 1999 and owned since 2025 by Tempus AI.
-
H
Genomics company in San Mateo, California, sequencing with its proprietary Exome+ assay in a CLIA certified, CAP accredited laboratory.
Price: No published price
-
A
Allelica, based in San Francisco, builds polygenic risk scores and sells them several ways.
Price: No published price
-
M
MyOme is a genomics company in Menlo Park, California, with a CLIA certified and CAP accredited laboratory, that sells whole genome screening built around integrated risk scores.
Price: No published price
-
G
Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories.
-
F
Foundation Medicine, based in Boston and a member of the Roche Group, runs comprehensive genomic profiling for cancer in its own laboratories.
Price: No published price
-
G
Rare disease genomic diagnosis company (NASDAQ: WGS) in Gaithersburg, Maryland, running exome and genome sequencing in its own accredited laboratory and interpreting it with automation, machine learning and clinical scientists over GeneDx Infinity, its dataset of prior cases.
Price: No published price
-
S
Cloud genomics analysis company (NASDAQ: SOPH) based in Rolle, Switzerland and Boston.
Price: No published price
-
G
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
Price: $949 per test (list price)
More Myriad Genetics comparisons
Side by side comparisons of Myriad Genetics with products not listed above.
Myriad Genetics alternatives, answered
What are the best alternatives to Myriad Genetics?
The closest alternatives to Myriad Genetics are Invitae, Ambry Genetics, Helix, Allelica and MyOme. Invitae is a genetic testing brand owned by Labcorp, which acquired the business in 2024 after Invitae's bankruptcy. Ambry Genetics is a genetic testing laboratory in Aliso Viejo, California, founded in 1999 and owned since 2025 by Tempus AI. Allelica, based in San Francisco, builds polygenic risk scores and sells them several ways.
Who are Myriad Genetics's competitors?
Myriad Genetics's competitors in the Diagnostics & Genomics category include Invitae, Ambry Genetics, Helix, Allelica, MyOme and Guardant Health.